ELIZABETH THORNTON: Open Payments
NPI 1538755673 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,625 in 72 payments from 23 companies in 2025. Trend: 2023 $1,589 · 2024 $1,355 · 2025 $1,625
Food & beverage: $1,530Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $252 |
| Daiichi Sankyo Inc. | 12 | $252 |
| Novartis Pharmaceuticals Corporation | 6 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $121 |
| Genmab U.S., Inc. | 5 | $113 |
| Astellas Pharma US Inc | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Incyte Corporation | 4 | $91 |
| BeOne Medicines USA, Inc. | 3 | $72 |
| Eisai Inc. | 3 | $70 |
Products named: Enhertu, ERLEADA, Tivdak, TALVEY, DATROWAY, MONJUVI, Nubeqa, Lenvima.
Industry payments across PA — which companies pay providers there.
